CVR: 45367282
EUR -256,439
Gross profit
Net result: EUR -272,818
CLAUS OLESEN HOLDING ApS, BODD ApS
2 more
CVR · view ownership and management
Owner registered: PHJ 2025 Holding ApS
CVR · 29/05/2026
View the full event history
Synuca Therapeutics ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2025. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of William Brown and Lasse Reimer. The company's owners include CLAUS OLESEN HOLDING ApS, BODD ApS and PHJ 2025 Holding ApS. In 2025, the company reported a gross profit of EUR -256,439 and a net result of EUR -272,818. Equity in the 2025 report amounted to EUR -267,462.
Selskabets formål er at drive virksomhed med forskning og udarbejdelse af stoffer, herunder til medicinalindustrien, samt enhver i forbindelse hermed stående virksomhed
Source: annual reports filed with the Danish Business Authority.
Compared to 1.041 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreSynuca Therapeutics ApS was founded on 30 January 2025.
Synuca Therapeutics ApS is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (industry code 721000).
The owners of Synuca Therapeutics ApS include CLAUS OLESEN HOLDING ApS, BODD ApS and PHJ 2025 Holding ApS.
In 2025, Synuca Therapeutics ApS reported a gross profit of EUR -256,439.
The management of Synuca Therapeutics ApS consists of William Brown and Lasse Reimer.
Synuca Therapeutics ApS is located at Ole Maaløes Vej 3, 2200 København N.
Claim this page to add your logo and social links. Free to get started.
Synuca Therapeutics ApS has published its annual report for 2025. Gross profit came to DKK -256,439, and the net result was DKK -272,818.
As of June 29, 2026, Claus Elsborg Olesen has joined the board of directors of Synuca Therapeutics ApS.
As of June 29, 2026, Anker Gunvald Lundemose has joined the board of directors of Synuca Therapeutics ApS.
As of June 29, 2026, Lasse Reimer has joined the board of directors of Synuca Therapeutics ApS.
As of May 29, 2026, PHJ 2025 Holding ApS is registered as an owner of Synuca Therapeutics ApS with an ownership share of 15%.
As of May 29, 2026, Raul Holding ApS is registered as an owner of Synuca Therapeutics ApS with an ownership share of 15%.
As of January 30, 2025, EY Godkendt Revisionspartnerselskab has been appointed auditor of Synuca Therapeutics ApS.
As of January 30, 2025, William Brown is registered as director of Synuca Therapeutics ApS.
As of January 30, 2025, Lasse Reimer is registered as director of Synuca Therapeutics ApS.
As of January 30, 2025, CLAUS OLESEN HOLDING ApS is registered as an owner of Synuca Therapeutics ApS with an ownership share of 25%.
As of January 30, 2025, BODD ApS is registered as an owner of Synuca Therapeutics ApS with an ownership share of 25%.
Synuca Therapeutics ApS was founded on January 30, 2025.
Companies in the same industry and area
CVR 45436497
CVR 46543912
CVR 44478587
CVR 31427169
CVR 43506242
